| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Seres Therapeutics, Inc. | Director | Stock Option (right to buy) | 100,000 | 10 Apr 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MCRB | Seres Therapeutics, Inc. | 10 Apr 2025 | 1 | $0 | 4 | Director | 11 Apr 2025, 16:05 |
| MCRB | Seres Therapeutics, Inc. | 01 Jul 2024 | 1 | $0 | 4 | Director | 03 Jul 2024, 16:15 |
| MCRB | Seres Therapeutics, Inc. | 04 Apr 2024 | 1 | $0 | 4 | Director | 08 Apr 2024, 16:45 |
| MCRB | Seres Therapeutics, Inc. | 22 Jun 2023 | 1 | $0 | 4 | Director | 23 Jun 2023, 17:22 |
| MCRB | Seres Therapeutics, Inc. | 22 Jun 2022 | 1 | $0 | 4 | Director | 24 Jun 2022, 16:35 |
| MCRB | Seres Therapeutics, Inc. | 22 Jun 2022 | 1 | $0 | 4 | Director | 24 Jun 2022, 16:32 |
| MCRB | Seres Therapeutics, Inc. | 16 Jun 2021 | 1 | $0 | 4 | Director | 21 Jun 2021, 16:30 |